Sort
141,003 grants matching “cytokine”
Innate Immune IL-10/STAT3 Signaling in Alzheimer's Disease
$2,792,837Jeannie Chen · University Of Southern California · RF1 · FY2017 · AG
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$2,791,527Sampa Santra · Beth Israel Deaconess Medical Center · N01 · FY2015 · AI
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,791,324Weill Medical College Of Cornell Univ · U01 · FY2000 · HL
Stress, Weathering, and Blood-Based Biomarkers of Alzheimerâs Disease: A Longitudinal Study of Low Income, Aging African Americans
$2,788,814Ronald L Simons · University Of Georgia · RF1 · FY2022 · AG
Allergic sensitization through the airway
$2,788,618Donald N Cook · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
WOMEN'S INTERAGENCY HIV STUDY (WIHS)
$2,788,288University Of Southern California · U01 · FY2000 · HD
Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling
$2,787,572Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Cytokine signaling, immunoregulation and autoimmune disease
$2,782,678John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2021 · AR
Molecular profiling and immunomodulatory interventions
$2,780,168Abraham Na Shaked · University Of Pennsylvania · U01 · FY2007 · AI
Development of anti-LPS therapeutic antibodies for the treatment of Pseudomonas aeruginosa infections
$2,779,955Mariette Barbier · West Virginia University · R01 · FY2025 · AI
Genes And Gene Products As Immunoadjuvants
$2,779,404Steven M Holland · Niaid Extramural Activities · Z01 · FY2007 · AI
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury
$2,776,920Yow-Pin Lim · Prothera Biologics, Llc · R44 · FY2023 · NS
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases
$2,773,603Raphaela Goldbach-Mansky · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD
$2,771,146Nirupama Putcha · Johns Hopkins University · U01 · FY2025 · AI
WOMENS INTERAGENCY HIV STUDY
$2,770,576Suny Downstate Medical Center · U01 · FY2002 · AI
Molecular Mechanisms Regulating Calcium Flux In Salivary Glands
$2,770,230Indu S. Ambudkar · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE
Development of a Vaccine for HIV-AIDS: Humoral Immunity
$2,762,142Marjorie Guroff · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,760,232Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2019 · CA
Systemic Autoimmunity
$2,759,908Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR
Optimizing HIV prevention for highly vulnerable methamphetamine-using sexual minority men
$2,758,797Christian Grov · Graduate School Of Public Health And Health Policy · UH3 · FY2024 · AI
Stat transcription factors in immunoregulation and autoimmune disease
$2,756,996John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$2,755,137Rachel R. Caspi · National Eye Institute · ZIA · FY2016 · EY
PACT
$2,751,701Leslie Eric Silberstein · Immune Disease Institute, Inc. · N01 · FY2010 · HL
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
$2,750,000Darby Thompson · The Emmes Company, Llc · N01 · FY2011 · EY
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses
$2,748,849Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2019 · AI